The Losartan Potassium Market in China did not experience any noticeable changes during the first week of December, just as it didn't experience any sharp changes at the end of November when prices were stable. The increase of 0.8% that occurred during November caused price consolidations, with supply and demand keeping pricing stable. Between November and December, there were no disruptions to manufacturing and production in the major production regions of China, resulting in enough availability and eliminating the need for an increase in supply. The export market has been consistent; however, much of the activity has been associated with pre-existing contract obligations and not necessarily due to increased demand for this product. Domestic procurement has remained cautious with manufacturers/producers engaging in controlled purchasing. Stable shipping conditions and lower shipping costs are also contributing to the stability of the market. Market participants anticipate that the current price levels will remain stable. There is anticipation of a slight decline in pricing before the end of December, largely because of oversupply and reduced domestic and export demand. For this reason, it is predicted that market sentiment will remain somewhat subdued through the end of December.
